From Yahoo Finance: 2025-05-14 08:27:00

Wall Street indices had a mixed finish as investors reacted to lower-than-expected inflation figures. The Consumer Price Index rose by 0.2% in April, with an annual rate of 2.3%, the lowest since February 2021. S&P 500 and Nasdaq saw gains, while Dow Jones dipped by 0.64%.

Halozyme Therapeutics, Inc. (HALO) plummeted by 24.56% on Tuesday to $50.23, due to news of CMS negotiating high-cost drug prices. This could impact biopharmaceutical companies like HALO, which focuses on developing human enzymes. Leerink Partners downgraded HALO’s stock and lowered the price target to $47.

Despite potential as an investment, HALO ranks as Tuesday’s worst performer. AI stocks are seen as holding greater promise for higher returns in a shorter timeframe. One AI stock has risen since the beginning of 2025, while popular AI stocks lost around 25%. Investors looking for a promising AI stock trading at less than 5 times its earnings can refer to the report on the cheapest AI stock.

Read more: Why Halozyme Therapeutics, Inc. (HALO) Declined on Tuesday